Welcome to Nutraceuticals World   
October 2014 Issue
Last Updated Wednesday, October 22 2014
Print

Zanthin XP-3 Astaxanthin



Published March 19, 2012
Valensa has launched a new astaxanthin formulation designed to provide optimal absorption at lower use levels. Called Zanthin XP-3 astaxanthin, the new product combines Valensa’s Zanthin natural astaxanthin with a supercritical extract perilla seed oil, O2B peroxidation blocker stabilization system and sunflower-based phospholipids in a synergistic formulation that enhances the human body’s absorption of the astaxanthin. Rather than adopt a strategy of large Astaxanthin doses to ensure the optimal 2 mg to 4 mg intake levels research has shown the body can utilize, Zanthin XP-3 typically makes the Astaxanthin 90% available across the board. For further information: www.valensa.com


Receive free Nutraceuticals World emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Nutraceuticals World On